Organization | Charta Fondazione

Charta Fondazione Report issue

Foundation

Organization Overview

First Clinical Trial

2009

NCT01051076

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2009

Timeline

NOW

Now

Active Ingredients

Drugs in Other Trials (2)

antihemophilic factor viii human (Hemofil M) (2 trials)

von Willebrand factor (recombinant) (Vonvendi) (2 trials)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 2
# of Trial APIs: 2